The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of body composition on outcomes from anti-programmed death-1 (PD-1) treatment.
 
Arissa Young
No Relationships to Disclose
 
Henry T. Quach
No Relationships to Disclose
 
Elizabeth J. Davis
Research Funding - Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst)
 
Javid Moslehi
Consulting or Advisory Role - Bristol-Myers Squibb; Deciphera; Ipsen; Myokardia; Novartis; Pfizer; Regeneron; Takeda
Research Funding - Bristol-Myers Squibb; Pfizer
 
Grant R. Williams
No Relationships to Disclose
 
Douglas Buckner Johnson
Consulting or Advisory Role - Array Biopharma; Bristol-Myers Squibb; Incyte; Merck; Novartis
Research Funding - Bristol-Myers Squibb; Incyte
Patents, Royalties, Other Intellectual Property - Intellectual property and patents pending surrounding use of MHC-II and response to immune therapy
Travel, Accommodations, Expenses - Genentech